Biodexa Pharmaceuticals Plc
BDRXNASDAQHealthcare● Active
$3.26
$-0.10(-2.98%)
Market Cap$546888
P/E Ratio—
52W High$66.5
52W Low$2.86
Biodexa Pharmaceuticals Plc（BDRX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BDRX · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.01B | $0.00B | $0.01B | $0.00B |
| Gross Profit | ($0.00B) | ($0.01B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Gross Margin %(computed) | — | — | -967.45% | -631.19% | -705.19% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.01B | $0.00B | $0.01B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Operating Income | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Income Tax Expense | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Income | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Net Margin %(computed) | — | — | — | — | -944.64% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-60.00 | $-1157000.00 | $-229000.00 | $-4943000.00 | $-3525000.00 |
| Wtd Avg Shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| EBITDA | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) |
| EBITDA Margin %(computed) | — | — | — | — | -979.07% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · GBP · B
深入了解Biodexa Pharmaceuticals Plc
关于Biodexa Pharmaceuticals Plc（BDRX）损益表
Biodexa Pharmaceuticals Plc（BDRX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，BDRX实现营收$0.00B，毛利润($0.00B)（毛利率—），净利润($0.01B)（净利率—）。
常见问题
BDRX · 4 问Biodexa Pharmaceuticals Plc（BDRX）2025财年营收为$0.00B，同比down—%。
BDRX revenueBDRX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08